Fortrea Holdings is a contract research organization providing phase I through IV biopharmaceutical product and medical device services, patient access solutions and other services. Co. provides its pharmaceutical, biotechnology, and medical device customers with clinical pharmacology, clinical development, and other service capabilities. Co. manages its business in two segments: Clinical Services, which brings solutions to market which include clinical pharmacology and clinical development capabilities; as well as Enabling Services, which provides patient access and technology solutions which can be deployed across any of its global solutions depending on the scope of its customers' needs. The FTRE YTD return is shown above.
The YTD Return on the FTRE YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether FTRE YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the FTRE YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|